HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Childhood shigellosis: clinical and bacteriological study.

Abstract
Ninety-three children with shigellosis were hospitalized in a regional hospital in Kuwait during the year 1988. S. flexneri was the most common isolate (54%) followed by S. sonnei (39%) and S. boydii (7%). In addition to the gastrointestinal manifestations, 14 patients (15%) developed generalized convulsions. The benign and self-limiting nature of the convulsions associated with shigellosis means that neither diagnostic procedure nor drug therapy are usually necessary. The disease was self-limiting in 41% and antimicrobial usage did not seem to shorten the duration of symptoms or hospital stay. All shigellae isolated were sensitive to gentamicin and amikacin, 56% were resistant to three or more antimicrobial agents, 32 were resistant to five or more. These findings may indicate the need for better control of antibiotic use, particularly in developing countries.
AuthorsA S Daoud, M Zaki, G al-Mutairi, P W West, Q el Saleh
JournalThe Journal of tropical medicine and hygiene (J Trop Med Hyg) Vol. 93 Issue 4 Pg. 275-9 (Aug 1990) ISSN: 0022-5304 [Print] England
PMID2202839 (Publication Type: Journal Article)
Chemical References
  • Gentamicins
  • Amikacin
Topics
  • Amikacin (pharmacology)
  • Breast Feeding
  • Child
  • Child, Preschool
  • Drug Resistance, Microbial
  • Dysentery, Bacillary (complications, epidemiology, microbiology)
  • Female
  • Gentamicins (pharmacology)
  • Humans
  • Infant
  • Kuwait (epidemiology)
  • Male
  • Seasons
  • Seizures (etiology)
  • Shigella (isolation & purification)
  • Shigella boydii (drug effects, isolation & purification)
  • Shigella flexneri (drug effects, isolation & purification)
  • Shigella sonnei (drug effects, isolation & purification)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: